Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Scinai Immunotherapeutics Logo
Scinai Immunotherapeutics Growth Score
89
CB Rank
5398
Heat Score
77
Scinai Immunotherapeutics is an innovative biopharmaceutical company.
Founded
obfuscation
PublicPost-IPO Equity Ness Ziona, HaMerkaz, Israel11-50 www.scinai.com
Biotechnology
Health Care
Information Technology
Overview

Scinai Immunotherapeutics
Total Funding
obfuscation
Growth Score
89
Heat Score
77

Total Funding
obfuscation
obfuscation
Post-IPO Equity raised
obfuscation
Growth Score89
-9 pts
in past quarter
Heat Score 77
-2 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Scinai Immunotherapeutics

CB Rank
5398
Scinai Immunotherapeutics is an innovative biopharmaceutical company.
Founded
obfuscation
PublicPost-IPO Equity Ness Ziona, HaMerkaz, Israel11-50 www.scinai.com
Biotechnology
Health Care
Information Technology

Funding Rounds

Post-IPO Equity
OBF
in
obfuscation
Grant
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation

Key People

Details

Sub-Organization of 
Yeda Research and Development Co. Ltd Logo
Yeda Research and Development Co. Ltd
Legal Name Scinai Immunotherapeutics Ltd
Also Known As BiondVax, BiondVax Pharmaceuticals, Scinai
Operating Status Active
Stock Symbol  NASDAQ:SCNI
Company Type For Profit
Founders  Ron Babecoff
About the Company
Scinai Immunotherapeutics is a biopharmaceutical company that focuses on research and development, manufacturing, and commercialization of innovative inflammation and immunology (I&I) biological products primarily for the treatment of autoimmune and infectious diseases.
Phone Number +972-8-930-2529
Contact Email info@scinai.com
Predictions & Insights

Growth Insight

See this Growth Insight
Scinai Immunotherapeutics is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Products & Services

Innovative Immunotherapeutic Treatments
Developing a range of nanosized antibody therapies derived from alpacas for autoimmune and infectious diseases.
Boutique CDMO
Offers pilot and clinical process development and manufacturing services for pharmaceutical, biotech, and alternative protein food tech companies.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 11
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Scinai Immunotherapeutics Logo
Post-IPO Equity - Scinai Immunotherapeutics
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Scinai Immunotherapeutics Logo
Post-IPO Equity - Scinai Immunotherapeutics
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Scinai Immunotherapeutics Logo
Post-IPO Equity - Scinai Immunotherapeutics
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Scinai Immunotherapeutics Logo
Post-IPO Equity - Scinai Immunotherapeutics
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Scinai Immunotherapeutics Logo
Post-IPO Equity - Scinai Immunotherapeutics
—
obfuscation
— Post-IPO Equity

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 11
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Scinai Immunotherapeutics Logo
Post-IPO Equity - Scinai Immunotherapeutics
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Scinai Immunotherapeutics Logo
Post-IPO Equity - Scinai Immunotherapeutics
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Scinai Immunotherapeutics Logo
Post-IPO Equity - Scinai Immunotherapeutics
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Scinai Immunotherapeutics Logo
Post-IPO Equity - Scinai Immunotherapeutics
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Scinai Immunotherapeutics Logo
Post-IPO Equity - Scinai Immunotherapeutics
—
obfuscation
— Post-IPO Equity

Investors

Investments

Number of Acquisitions 2

Investment Breakdown

Number of Acquisitions 2
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 8 Board Members and Advisors 1 Contacts 12

Employee Profiles

Board Members and Advisors

News

News and Press

News•Jun 10, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 9, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 20, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 20, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

690

Actively Used Products

9Scinai Immunotherapeutics uses 9 technology products and services including HTML5, DigiCert, and  F5 NGINX, according to G2 Stack.

Active Website Tech Count

19Scinai Immunotherapeutics is actively using 19 technologies for its website, according to BuiltWith. These include jsDelivr, CommonCrawl Top 5m, and  Person Schema.

Total IP

8Scinai Immunotherapeutics has registered 8 trademarks with the most popular class being 'Pharmaceutical, veterinary and sanitary products', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Scinai Immunotherapeutics's headquarters? Scinai Immunotherapeutics is located in Ness Ziona, HaMerkaz, Israel.Who invested in Scinai Immunotherapeutics? Scinai Immunotherapeutics has 4 investors including Israel Innovation Authority and  RK Stone Miami.When was the last funding round for Scinai Immunotherapeutics? Scinai Immunotherapeutics closed its last funding round on
obfuscation
from a Post-IPO Equity round.How much funding has Scinai Immunotherapeutics raised to date? Scinai Immunotherapeutics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(3e39328 1)
|